Advancing the World of Health (original) (raw)
BD completes acquisition of Critical Care from Edwards Lifesciences
BD completes acquisition of Critical Care from Edwards Lifesciences
Business renamed as BD Advanced Patient Monitoring
Advancing the world of health™
See how BD is made for today, tomorrow and for what’s needed next
Supporting Syringe Supply Continuity
BD has capacity to support increased syringe demand with proven performance and quality
Working Together to Help Eliminate Cervical Cancer
Shaping the future of women’s health
BD Celebrates Associate Volunteers
Volunteer Service Trips advance health equity
Advancing Patient Safety
Supporting your efforts to address infection risk factors
NEWS
BD Receives FDA 510(k) Clearance for Advanced Microbiology Solution
Integration of BD Phoenix™ Automated Microbiology System, BDXpert™ System and BD Synapsys™ Informatics Solution Supports Accurate Detection of Antimicrobial Resistance FRANKLIN LAKES, N.J....
Learn More
NEWS
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to...
Learn More
BLOG
Celebrating BD Innovation Excellence
Since 2000, the Howe Awards have celebrated creative excellence in technology, honoring those who blend science, technology, engineering, and our core values.
Learn More
Our Portfolio
Supporting you across healthcare settings
Careers
People, Purpose, and Possibilities
At BD, we believe that people are at the heart of every breakthrough, solution, and step forward. Our Purpose drives us to create innovative solutions that make a meaningful impact on _advancing the world of health_™. We know that possibilities are endless when people feel supported and inspired. From our robust benefits to our inclusive, growth-focused culture, we’re here to help you thrive both professionally and personally.
Join us and become a maker of possible.